Keep up-to-date with important developments in IP, upcoming events and our latest thinking by subscribing to our IP newsletter - Perspectives.
The proposed EU design reform package seeks to rejuvenate, harmonise and modernise a system that was originally implemented 20 years ago. Anne-Catherine Schihin sets out its main objectives, including the green goals of the new repair clause.
Counterfeiting and piracy are constant challenges for brand owners in both online and offline channels. The Anti-counterfeiting Benchmarking Report released by the International Trademark Association (INTA) in May provides valuable insights and counterfeiting statistics that illuminate the scale of the problem and the resources necessary to address it.
Component parts of complex objects that are not visible during ‘normal use’ of the object do not enjoy design protection in Europe. But what constitutes a component part of a complex object? Volha Parfenchyk shares a recent ruling by the EU General Court that provides some clarification.
Just because a patent has been granted does not mean it cannot be disputed. Vincent Robert explains the procedure for patent oppositions in the EU, including when and how it can be used.
In affirming the EUIPO’s decision to refuse the registration of a figurative mark for confectionery containers, the EU General Court has confirmed that the principles developed in the context of 3D trademarks are also applicable to 2D trademarks.
Rebekah Vardy has successfully registered WAGATHA CHRISTIE as a UK trademark after a recent libel case hit the tabloids, but is it vulnerable to bad faith?
The Boards of Appeal of the European Patent Office (EPO) recently ruled in a case concerning sufficient disclosure for a patent application related to wind turbines. Robert Balsters examines the decision and what it means for mechanical patents.
After much dispute, discussion and delay, the Unified Patent Court launch officially took place this morning at 9 am CET (1 June 2023). Organisations can now benefit from a new unitary patent (UP) right and access the new Europe-wide patent court system (UPC).
In disputes over pharmaceutical trademarks, the courts take a precautionary approach to exclude any risk of confusion between two medicines marketed under similar brand names. However, this restrictive approach has been qualified by EU case law, as Florence Chapin explains.